Revolution Medicines is dedicated to discovering, developing, and delivering innovative targeted medicines for cancer patients. The company focuses on RAS-addicted cancers, which represent 30 percent of new human cancer diagnoses. Revolutionaries work tirelessly to develop cutting-edge therapeutic approaches, setting them apart in the industry with their commitment to tackling some of the toughest cancers.
Revolution Medicines is seeking a Vice President, Regulatory Science to lead a high-functioning team focused on expanding and scaling regulatory strategy for a new line of anti-RAS therapies. The role involves ensuring high-quality regulatory research, influencing decision-making, and collaborating with functional heads to integrate regulatory considerations into all aspects of project development and commercialization. The company focuses on developing precision oncology therapeutics with targeted approaches to RAS signaling pathways.
Revolution Medicines is dedicated to discovering, developing, and delivering innovative targeted medicines for cancer patients. The company focuses on RAS-addicted cancers, which represent 30 percent of new human cancer diagnoses. Revolutionaries work tirelessly to develop cutting-edge therapeutic approaches, setting them apart in the industry with their commitment to tackling some of the toughest cancers.